The costlier ThinPrep smear test is winning converts claim its US developers
This article was originally published in Clinica
Executive Summary
Cytyc has made "enormous progress" this year in convincing managed care organisations in the US to cover its ThinPrep smear test for cervical cancer, according to company president and CEO Patrick Sullivan.